CH
CVS icon

Canton Hathaway’s CVS Health CVS Stock Holding History

Canton Hathaway’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.9K Sell
486
-21
-4% -$1.62K 0.01% 223
2025
Q4 		$40.2K Hold
507
– – 0.01% 217
2025
Q3 		$38K Buy
507
+43
+9% +$2.95K 0.01% 223
2025
Q2 		$32K Buy
464
+8
+2% +$525 0.01% 233
2025
Q1 		$31K Hold
456
– – 0.01% 231
2024
Q4 		$20K Hold
456
– – 0.01% 247
2024
Q3 		$29K Hold
456
– – 0.01% 210
2024
Q2 		$27K Sell
456
-4,000
-90% -$250K 0.01% 210
2024
Q1 		$355K Hold
4,456
– – 0.1% 72
2023
Q4 		$352K Hold
4,456
– – 0.11% 68
2023
Q3 		$311K Sell
4,456
-1,500
-25% -$106K 0.1% 66
2023
Q2 		$412K Hold
5,956
– – 0.13% 66
2023
Q1 		$443K Hold
5,956
– – 0.15% 60
2022
Q4 		$555K Sell
5,956
-22,725
-79% -$2.19M 0.19% 57
2022
Q3 		$2.73M Buy
28,681
+4,850
+20% +$480K 1% 15
2022
Q2 		$2.21M Buy
23,831
+200
+0.8% +$19.5K 0.77% 24
2022
Q1 		$2.39M Sell
23,631
-250
-1% -$26.3K 0.67% 28
2021
Q4 		$2.46M Sell
23,881
-1,625
-6% -$150K 0.67% 30
2021
Q3 		$2.16M Buy
25,506
+19,756
+344% +$1.65M 0.62% 31
2021
Q2 		$480K Hold
5,750
– – 0.14% 75
2021
Q1 		$433K Hold
5,750
– – 0.14% 77
2020
Q4 		$393K Buy
5,750
+250
+5% +$16.3K 0.13% 79
2020
Q3 		$321K Hold
5,500
– – 0.13% 71
2020
Q2 		$357K Hold
5,500
– – 0.23% 51
2020
Q1 		$326K Sell
5,500
-5,870
-52% -$392K 0.23% 47
2019
Q4 		$845K Hold
11,370
– – 0.43% 31
2019
Q3 		$717K Buy
11,370
+805
+8% +$47.7K 0.4% 35
2019
Q2 		$576K Buy
10,565
+1,634
+18% +$88K 0.32% 40
2019
Q1 		$481K Sell
8,931
-2,544
-22% -$157K 0.28% 43
2018
Q4 		$752K Buy
11,475
+9,875
+617% +$737K 0.49% 20
2018
Q3 		$126K Buy
+1,600
New +$114K 0.08% 65

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Canton Hathaway's CVS Position: Q1 2026 in Review

Canton Hathaway reduced its CVS Health (CVS) stake by 4.1% in Q1 2026, selling an estimated $1.62K and leaving 486 shares worth $34.9K. The position accounts for 0.01% of the portfolio, ranked #223.

Canton Hathaway first reported a position in CVS in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.73M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Canton Hathaway held 486 shares of CVS Health worth $34.9K as of Q1 2026.
  • Canton Hathaway sold 21 CVS Health shares in Q1 2026, an estimated $1.62K.
  • CVS Health made up 0.01% of Canton Hathaway's portfolio in Q1 2026, its #223 holding.
  • Canton Hathaway first reported a position in CVS Health in Q3 2018 and has held it in 31 quarters since.
  • Canton Hathaway's CVS Health position peaked at $2.73M in Q3 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.